|
[1] Chinese Society of Hepatology,Chinese Society of Gastroenterology,Chinese Medical Association. Clinical guidelines on nutrition in end-stage liver disease[J]. J Clin Hepatol,2019,35(6):1222-1230.(in Chinese)中华医学会肝病学分会，中华医学会消化病学分会．终末期肝病临床营养指南[J]．临床肝胆病杂志，2019,35(6):1222-1230.
|
|
[2] MONTANO-LOZA AJ. Clinical relevance of sarcopenia in patients with cirrhosis[J]. World J Gastroenterol,2014,20(25):8061-8071.
|
|
[3] TRUSWELL AS. Standardization of nomenclature of body composition in weight loss[J]. Am J Clin Nutr,1998,67(3):492-493.
|
|
[4] JONES SE,MADDOCKS M,KON SS,et al. Sarcopenia in COPD:Prevalence,clinical correlates and response to pulmonary rehabilitation[J]. Thorax,2015,70(3):213-218.
|
|
[5] de BLASIO F,di GREGORIO A,de BLASIO F,et al. Malnutrition and sarcopenia assessment in patients with chronic obstructive pulmonary disease according to international diagnostic criteria,and evaluation of raw BIA variables[J]. Respir Med,2018,134:1-5.
|
|
[6] SINCLAIR M,GOW PJ,GROSSMANN M,et al. Review article:Sarcopenia in cirrhosis—aetiology,implications and potential therapeutic interventions[J]. Aliment Pharmacol Ther,2016,43(7):765-777.
|
|
[7] DASARATHY S,MERLI M. Sarcopenia from mechanism to diagnosis and treatment in liver disease[J]. J Hepatol,2016,65(6):1232-1244.
|
|
[8] KIM G,KANG SH,KIM MY,et al. Prognostic value of sarcopenia in patients with liver cirrhosis:A systematic review and meta-analysis[J]. PLo S One,2017,12(10):e0186990.
|
|
[9] CRUZ-JENTOFT AJ,BAEYENS JP,BAUER JM,et al. Sarcopenia:European consensus on definition and diagnosis:Report of the European Working Group on Sarcopenia in Older People[J]. Age Ageing,2010,39(4):412-423.
|
|
[10] FIELDING RA,VELLAS B,EVANS WJ,et al. Sarcopenia:An undiagnosed condition in older adults. Current consensus definition:Prevalence,etiology,and consequences. International working group on sarcopenia[J]. J Am Med Dir Assoc,2011,12(4):249-256.
|
|
[11] CHEN LK,LIU LK,WOO J,et al. Sarcopenia in Asia:Consensus report of the Asian Working Group for Sarcopenia[J].J Am Med Dir Assoc,2014,15(2):95-101.
|
|
[12] PENG TC,WU LW,CHEN WL,et al. Nonalcoholic fatty liver disease and sarcopenia in a Western population(NHANES III):The importance of sarcopenia definition[J]. Clin Nutr,2019,38(1):422-428.
|
|
[13] MENG NH,LI CI,LIU CS,et al. Comparison of height-and weight-adjusted sarcopenia in a Taiwanese metropolitan older population[J]. Geriatr Gerontol Int,2015,15(1):45-53.
|
|
[14] SHEN W,PUNYANITYA M,WANG Z,et al. Total body skeletal muscle and adipose tissue volumes:Estimation from a single abdominal cross-sectional image[J]. J Appl Physiol(1985),2004,97(6):2333-2338.
|
|
[15] CAREY EJ,LAI JC,WANG CW,et al. A multicenter study to define sarcopenia in patients with end-stage liver disease[J]. Liver Transpl,2017,23(5):625-633.
|
|
[16] CRUZ-JENTOFT AJ,BAHAT G,BAUER J,et al. Sarcopenia:Revised European consensus on definition and diagnosis[J]. Age Ageing,2019,48(4):601.
|
|
[17] European Association for the Study of the Liver. EASL clinical practice guidelines on nutrition in chronic liver disease[J]. J Hepatol,2019,70(1):172-193.
|
|
[18] MONTANO-LOZA AJ,MEZA-JUNCO J,PRADO CM,et al.Muscle wasting is associated with mortality in patients with cirrhosis[J]. Clin Gastroenterol Hepatol,2012,10(2):166-173.
|
|
[19] TANDON P,NEY M,IRWIN I,et al. Severe muscle depletion in patients on the liver transplant wait list:Its prevalence and independent prognostic value[J]. Liver Transpl,2012,18(10):1209-1216.
|
|
[20] DURAND F,BUYSE S,FRANCOZ C,et al. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography[J]. J Hepatol,2014,60(6):1151-1157.
|
|
[21] HANAI T,SHIRAKI M,NISHIMURA K,et al. Sarcopenia impairs prognosis of patients with liver cirrhosis[J]. Nutrition,2015,31(1):193-199.
|
|
[22] KALAFATELI M,MANTZOUKIS K,CHOI YY,et al. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score[J]. J Cachexia Sarcopenia Muscle,2017,8(1):113-121.
|
|
[23] KUO SZ,AHMAD M,DUNN MA,et al. Sarcopenia predicts posttransplant mortality in acutely ill men undergoing urgent evaluation and liver transplantation[J]. Transplantation,2019.[Epub ahead of print]
|
|
[24] MERLI M,GIUSTO M,LUCIDI C,et al. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy:Results of a prospective study[J]. Metab Brain Dis,2013,28(2):281-284.
|
|
[25] HARA N,IWASA M,SUGIMOTO R,et al. Sarcopenia and sarcopenic obesity are prognostic factors for overall survival in patients with cirrhosis[J]. Intern Med,2016,55(8):863-870.
|
|
[26] MONTANO-LOZA AJ,ANGULO P,MEZA-JUNCO J,et al.Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis[J]. J Cachexia Sarcopenia Muscle,2016,7(2):126-135.
|
|
[27] QUIGLEY EM,STANTON C,MURPHY EF. The gut microbiota and the liver. Pathophysiological and clinical implications[J].J Hepatol,2013,58(5):1020-1027.
|
|
[28] TSIEN C,DAVULURI G,SINGH D,et al. Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis[J]. Hepatology,2015,61(6):2018-2029.
|
|
[29] SINCLAIR M,GROSSMANN M,HOERMANN R,et al. Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone:A randomised controlled trial[J]. J Hepatol,2016,65(5):906-913.
|
|
[30] CHEN HW,DUNN MA. Muscle at risk:The multiple impacts of ammonia on sarcopenia and frailty in cirrhosis[J]. Clin Transl Gastroenterol,2016,7:e170.
|
|
[31] GARCÍA PS,CABBABE A,KAMBADUR R,et al. Brief-reports:Elevated myostatin levels in patients with liver disease:A potential contributor to skeletal muscle wasting[J]. Anesth Analg,2010,111(3):707-709.
|
|
[32] QIU J,TSIEN C,THAPALAYA S,et al. Hyperammonemiamediated autophagy in skeletal muscle contributes to sarcopenia of cirrhosis[J]. Am J Physiol Endocrinol Metab,2012,303(8):e983-e993.
|
|
[33] DASARATHY J,MCCULLOUGH AJ,DASARATHY S. Sarcopenia in alcoholic liver disease:Clinical and molecular advances[J].Alcohol Clin Exp Res,2017,41(8):1419-1431.
|
|
[34] HAYASHI F,MATSUMOTO Y,MOMOKI C,et al. Physical inactivity and insufficient dietary intake are associated with the frequency of sarcopenia in patients with compensated viral liver cirrhosis[J]. Hepatol Res,2013,43(12):1264-1275.
|
|
[35] DUAN ZP. Nutrition of patients with liver diseases:What is the highlight[J]. J Pract Hepatol,2014,17(5):449-451.(in Chinese)段钟平．肝病营养问题再关注[J]．实用肝脏病杂志，2014,17(5):449-451.
|
|
[36] PLAUTH M,BERNAL W,DASARATHY S,et al. ESPEN guideline on clinical nutrition in liver disease[J]. Clin Nutr,2019,38(2):485-521.
|
|
[37] KAIDO T,OGAWA K,FUJIMOTO Y,et al. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation[J]. Am J Transplant,2013,13(6):1549-1556.
|
|
[38] NASEER M,TURSE EP,SYED A,et al. Interventions to improve sarcopenia in cirrhosis:A systematic review[J]. World J Clin Cases,2019,7(2):156-170.
|
|
[39] ROMÁN E,TORRADES MT,NADAL MJ,et al. Randomized pilot study:Effects of an exercise programme and leucine supplementation in patients with cirrhosis[J]. Dig Dis Sci,2014,59(8):1966-1975.
|
|
[40] YURCI A,YUCESOY M,UNLUHIZARCI K,et al. Effects of testosterone gel treatment in hypogonadal men with liver cirrhosis[J]. Clin Res Hepatol Gastroenterol,2011,35(12):845-854.
|
DownLoad: